259 related articles for article (PubMed ID: 19474810)
1. PML has a predictive role in tumor cell permissiveness to interferon-sensitive oncolytic viruses.
Sobol PT; Hummel JL; Rodrigues RM; Mossman KL
Gene Ther; 2009 Sep; 16(9):1077-87. PubMed ID: 19474810
[TBL] [Abstract][Full Text] [Related]
2. The two functions of herpes simplex virus 1 ICP0, inhibition of silencing by the CoREST/REST/HDAC complex and degradation of PML, are executed in tandem.
Gu H; Roizman B
J Virol; 2009 Jan; 83(1):181-7. PubMed ID: 18945770
[TBL] [Abstract][Full Text] [Related]
3. Complementation of a herpes simplex virus ICP0 null mutant by varicella-zoster virus ORF61p.
Kyratsous CA; Walters MS; Panagiotidis CA; Silverstein SJ
J Virol; 2009 Oct; 83(20):10637-43. PubMed ID: 19656893
[TBL] [Abstract][Full Text] [Related]
4. Differential functions of interferon-upregulated Sp100 isoforms: herpes simplex virus type 1 promoter-based immediate-early gene suppression and PML protection from ICP0-mediated degradation.
Negorev DG; Vladimirova OV; Maul GG
J Virol; 2009 May; 83(10):5168-80. PubMed ID: 19279115
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation.
Cuchet-Lourenço D; Vanni E; Glass M; Orr A; Everett RD
J Virol; 2012 Oct; 86(20):11209-22. PubMed ID: 22875967
[TBL] [Abstract][Full Text] [Related]
6. Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects.
Chee AV; Lopez P; Pandolfi PP; Roizman B
J Virol; 2003 Jun; 77(12):7101-5. PubMed ID: 12768029
[TBL] [Abstract][Full Text] [Related]
7. Identification of three redundant segments responsible for herpes simplex virus 1 ICP0 to fuse with ND10 nuclear bodies.
Zheng Y; Gu H
J Virol; 2015 Apr; 89(8):4214-26. PubMed ID: 25631093
[TBL] [Abstract][Full Text] [Related]
8. Two overlapping regions within the N-terminal half of the herpes simplex virus 1 E3 ubiquitin ligase ICP0 facilitate the degradation and dissociation of PML and dissociation of Sp100 from ND10.
Perusina Lanfranca M; Mostafa HH; Davido DJ
J Virol; 2013 Dec; 87(24):13287-96. PubMed ID: 24089549
[TBL] [Abstract][Full Text] [Related]
9. STAT-1- and IRF-3-dependent pathways are not essential for repression of ICP0-null mutant herpes simplex virus type 1 in human fibroblasts.
Everett RD; Young DF; Randall RE; Orr A
J Virol; 2008 Sep; 82(17):8871-81. PubMed ID: 18579584
[TBL] [Abstract][Full Text] [Related]
10. A Tale of Two PMLs: Elements Regulating a Differential Substrate Recognition by the ICP0 E3 Ubiquitin Ligase of Herpes Simplex Virus 1.
Zheng Y; Samrat SK; Gu H
J Virol; 2016 Dec; 90(23):10875-10885. PubMed ID: 27681131
[TBL] [Abstract][Full Text] [Related]
11. The viral ubiquitin ligase ICP0 is neither sufficient nor necessary for degradation of the cellular DNA sensor IFI16 during herpes simplex virus 1 infection.
Cuchet-Lourenço D; Anderson G; Sloan E; Orr A; Everett RD
J Virol; 2013 Dec; 87(24):13422-32. PubMed ID: 24089555
[TBL] [Abstract][Full Text] [Related]
12. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0.
Everett RD; Rechter S; Papior P; Tavalai N; Stamminger T; Orr A
J Virol; 2006 Aug; 80(16):7995-8005. PubMed ID: 16873256
[TBL] [Abstract][Full Text] [Related]
13. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.
Westcott MM; Liu J; Rajani K; D'Agostino R; Lyles DS; Porosnicu M
J Virol; 2015 Aug; 89(15):7944-54. PubMed ID: 25995245
[TBL] [Abstract][Full Text] [Related]
14. Dynamic Response of IFI16 and Promyelocytic Leukemia Nuclear Body Components to Herpes Simplex Virus 1 Infection.
Everett RD
J Virol; 2016 Jan; 90(1):167-79. PubMed ID: 26468536
[TBL] [Abstract][Full Text] [Related]
15. The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0.
Maul GG; Everett RD
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1223-33. PubMed ID: 8207389
[TBL] [Abstract][Full Text] [Related]
16. Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling.
Moerdyk-Schauwecker M; Shah NR; Murphy AM; Hastie E; Mukherjee P; Grdzelishvili VZ
Virology; 2013 Feb; 436(1):221-34. PubMed ID: 23246628
[TBL] [Abstract][Full Text] [Related]
17. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator.
Regad T; Saib A; Lallemand-Breitenbach V; Pandolfi PP; de Thé H; Chelbi-Alix MK
EMBO J; 2001 Jul; 20(13):3495-505. PubMed ID: 11432836
[TBL] [Abstract][Full Text] [Related]
18. PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0.
Boutell C; Orr A; Everett RD
J Virol; 2003 Aug; 77(16):8686-94. PubMed ID: 12885887
[TBL] [Abstract][Full Text] [Related]
19. PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication.
Cuchet D; Sykes A; Nicolas A; Orr A; Murray J; Sirma H; Heeren J; Bartelt A; Everett RD
J Cell Sci; 2011 Jan; 124(Pt 2):280-91. PubMed ID: 21172801
[TBL] [Abstract][Full Text] [Related]
20. N-terminal phosphorylation sites of herpes simplex virus 1 ICP0 differentially regulate its activities and enhance viral replication.
Mostafa HH; Thompson TW; Davido DJ
J Virol; 2013 Feb; 87(4):2109-19. PubMed ID: 23221554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
